| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |